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Background and aims: Cardiovascular disease (CVD) is the leading cause of death in the Middle East. We sought to
study the prevalence and coexistence of 6 cardiovascular risk factors (RFs) among patients who underwent
percutaneous coronary intervention (PCI), and to evaluate the impact of age and gender on the presence of multiple
RFs. Methods and results. In this prospective, multicenter study, 2426 consecutive patients were enrolled. Mean age
was 59.0 þ 10.1 years and 500 (20.6%) were women. Acute coronary syndrome and stable coronary disease were the
indications for PCI in 77.1% and 22.9%, respectively. Hypertension was present in 62.3%, diabetes in 53.8%,
hypercholesterolemia in 48.8%, smoking in 43.5%, family history of premature CVD 39.4% and obesity in 28.8%. Only
3.8% did not have any of these RFs. Presence of P3 and P4 RFS was observed in 57.4% and 29.5% of patients,
respectively. Presence of P3 RFs was more common in women than men (69.0% vs. 54.5%, p < 0.0001), and among
patients 41–65 years of age than older or younger patients (60.1% vs. 52.0% vs. 48.3%, respectively, p = 0.017). Conclusions:
Cardiovascular RFs are highly prevalent in this PCI Middle Eastern population undergoing PCI. More than half and
more than one-fourth of the patients had at least 3 or 4 RFs; respectively. More women than men and more middle aged
patients than older or younger patients had significantly higher rates of presence of multiple RFs.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Cardiovascular disease, Risk factors, Middle Eastern patients, Percutaneous coronary interventione CC BY-
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Abbreviations
ACS acute coronary syndrome
BMI body mass index
CAD coronary artery disease
CVD cardiovascular disease
DM diabetes mellitus
JoPCR1 The first Jordanian PCI Registry
HbA1c glycosylated hemoglobin
HTN hypertension
NSTEACS non-ST-segment elevation ACS
PCI percutaneous coronary intervention
RF risk factor
SD standard deviation
STEMI ST-segment elevation myocardial infarction
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Cardiovascular disease (CVD) is the leadingcause of death worldwide and in the Middle
East [1–3]. By 2020, the mortality burden from
noncommunicable diseases, mostly attributable
to CVD, is expected to occur mainly in low- and
middle-income countries [4]. International [5,6]
and regional [7–10] studies have identified a set
of common CVD risk factors (RFs) that are found
to be highly prevalent in Middle Eastern commu-
nities, including hypertension (HTN), diabetes
mellitus (DM), hypercholesterolemia, obesity,
cigarette smoking, physical inactivity, family his-
tory of premature CVD, and poor diet.
The vast majority (P90%) of Middle Eastern
patients diagnosed to have coronary artery dis-
ease (CAD) have at least one of the four classical
RFs, i.e., HTN, DM, cigarette smoking, and hyper-
cholesterolemia, and the coexistence of two or
more RFs [11,12] or three or more RFs [5,8,10] is
present in the majority of these patients. The pres-
ence of multiple cardiovascular RFs negatively
impacts patient prognosis by potentiating the
development of atherosclerosis [13] and increas-
ing the intensity, diversity, and cost of long-term
medical care. Prevalence of RFs has not been stud-
ied in an exclusive percutaneous coronary inter-
vention (PCI) population in this region. The
studies that addressed the prevalence of RFs
involved patients admitted with acute coronary
syndrome (ACS) and treated conservatively or
those who underwent coronary angiography and
subsequent PCI or coronary surgical revascular-
ization [7–9], patients diagnosed to have stable
coronary disease who did not have coronary
angiography [8], patients who sustained cere-
brovascular events [6], or individuals assessed in
an outpatient clinic setup [5,10].
Data from the recently completed first Jordanian
PCI Registry were analyzed to determine the
prevalence of six cardiovascular RFs among
patients who underwent PCI for ACS or stable
coronary disease.2. Methods
2.1. Study population
The first Jordanian PCI Registry is a multicenter,
prospective study that enrolled consecutive
patients who underwent PCI in 12 tertiary care
centers in Jordan (January 2013–February 2014)
and were then followed up for 1 year after the
index hospitalization. Patients signed an informedPlease cite this article in press as: Hammoudeh A.J. et al., Cardiovascular r
nary intervention: Results from the first Jordanian percutaneous corona
10.1016/j.jsha.2016.10.002consent form prior to entry to the study. The two
major indications for PCI were ACS, including
ST-segment elevation myocardial infarction and
non-ST-segment elevation ACS, or stable coro-
nary disease, including chronic stable angina
and silent ischemia. The prevalence rates of the
following six RFs were assessed in every patient
during the index hospital stay: HTN, DM, cigar-
ette smoking, hypercholesterolemia, obesity, and
family history of premature CVD.
2.1. Study measures
All RFs were defined according to standard def-
initions [14]. Patients were considered to have
HTN if they had either systolic blood pressure ele-
vated above 140 mmHg and/or diastolic blood
pressure above 90 mmHg on several occasions
during hospital stay, were diagnosed to have
HTN, or were prescribed anti-HTN medications
by a treating physician. DM was defined accord-
ing to the standard criteria set by the American
Diabetes Association, i.e., fasting serum glucose
P126 mg/dL, 2-hour glucose level P200 mg/dL,
or glycosylated hemoglobin value P6.5%. DM
was also diagnosed in patients who had unequiv-
ocal hyperglycemia and classical symptoms of DM
(polyuria, polydipsia, and unexplained weight
loss) and casual plasma glucose P200 mg/dL,
and those with a prior diagnosis of DM or who
were prescribed antidiabetic medications by a
treating physician [15,16]. Body mass index (BMI)
was calculated according to the standard formula
[body weight (kg)/height (m2)]. Weight and height
were measured as early as possible after hospital
admission and when the clinical situation of each
patient was stable enough to allow taking these
measurements. Patients who were cigarette smok-
ers at enrollment were considered current smok-
ers. Patients who never smoked and past
smokers who quit at least 1 month prior to enroll-isk factors in Middle Eastern patients undergoing percutaneous coro-
ry intervention study, J Saudi Heart Assoc (2016), http://dx.doi.org/
Table 1. Demographic, clinical, and angiographic features of
the study patients.
Feature %
Age (y), mean ± SD 59.0 ± 10.1
Females 20.6
Hypertension 62.3
Diabetes mellitus 53.6
Hypercholesterolemia 48.8
Current smoker 43.5
Mean BMI (kg/m2) 28.5 ± 4.5
<25 22.6
25–29.9 48.6
P30 28.8
Chronic kidney disease 50 (2.7)
Past myocardial infarction 10.8
Past stroke 2.1
Peripheral arterial disease 0.9
Prior PCI 24.3
Prior coronary artery bypass surgery 3.5
ST-segment deviation 48.6
Elevated serum cardiac biomarkers 40.0
LVEF < 45% 12.5
Heart failure on admission 11.1
Diagnosis
ACS 77.1
STEMI 29.9
NSTEACS 47.2
Stable coronary syndrome: 22.9
Chronic stable angina 20.6
Silent ischemia 2.3
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CORONARY INTERVENTIONment were considered nonsmokers. Patients were
considered to have hypercholesterolemia if they
had a past diagnosis by a treating physician, were
prescribed lipid-lowering agents, or were found to
have serum total cholesterol >240 mg/dL during
the index admission. Obesity was defined as
BMI of P30 kg/m2. A family history of premature
CVD was defined as myocardial infarction, coro-
nary revascularization, or sudden death before
55 years of age in father or any other male first-
degree relative, or before 65 years of age in mother
or any other female first-degree relative. This
study was approved by the Institutional Review
Board in each of the participating hospitals.
Statistical analysis
IBM SPSS Statistics 20 (IBM Corp., Armonk, NY,
USA, 2011) was used for data entry and analysis.
Data were described using mean values ± stan-
dard deviation for continuous variables. Frequen-
cies and percentages were used to describe
categorical variables. The differences in percent-
ages of RFs among men and women, and among
the three prespecified age groups were analyzed
using chi-square test. A p value of <0.05 was con-
sidered statistically significant.Number of diseased coronary arteries
1 58.4
2 29.6
P3 12.0
Treated coronary arteries with PCI
1 coronary artery 71.4
2 coronary arteries 23.4
P3 coronary arteries 5.6
PCI of left main coronary artery 1.2
PCI of saphenous vein graft 1.0
ACS = acute coronary syndrome; BMI = body mass index; LVEF = left
ventricular ejection fraction; NSTEACS = non-ST-segment elevation
acute coronary syndrome; PCI = percutaneous coronary intervention;
SD = standard deviation; STEMI = ST-segment myocardial infarction.Results
A total of 2426 patients were enrolled consecu-
tively in the study. Their mean age (±standard
deviation) was 59.0 ± 10.1 years, and 500 (20.6%)
of them were women. There were 114 patients
(4.7%) younger than 41 years of age, 1679 (69.2%)
were 41–65 years of age, and 633 (26.1%) were
older than 65 years of age. PCI was indicated for
ACS in 1870 patients (77.1%) and for stable coro-
nary disease in 556 patients (22.9%). Patients
who had ACS were diagnosed to have either ST-
segment elevation myocardial infarction (725;
38.8%) or non-ST-segment elevation ACS (1145;
61.2%).
Table 1 shows the baseline clinical profiles, coro-
nary angiographic features, and PCI procedure
details in the whole group, and Fig. 1 depicts the
overall prevalence of the six prespecified RFs.
The presence of HTN was confirmed in all
patients based on a prior diagnosis of this RF
rather than on blood pressure measurements dur-
ing admission. The majority of diabetic (90%) and
hypercholesterolemic (95%) patients had these
diagnoses prior to admission, and the other
patients (10% of diabetic and 5% of hypercholes-
terolemic patients) had the diagnoses made based
on the results of blood tests during admission.Please cite this article in press as: Hammoudeh A.J. et al., Cardiovascular r
nary intervention: Results from the first Jordanian percutaneous corona
10.1016/j.jsha.2016.10.002Only 3.8% of patients did not have any of these
RFs. A past history of myocardial infarction and
that of PCI were present in 11% and 24% of
patients, respectively. Nearly 60% of patients had
single-vessel CAD and 70% single-vessel PCI.
The prevalence of RFs is shown in Fig. 2. Two or
more RFs were observed in 82.0% of patients. At
least three RFs were present in 57.4% of patients
and at least four RFs were present in 29.5%. Table 2
demonstrates the coexistence of each of thefiveRFs
(smoking, DM, HTN, obesity, and hypercholes-
terolemia) with the other RFs. The presence of at
least three RFs was observed in 54.8% of obese
patients, 51.0%of thosewithhypercholesterolemia,isk factors in Middle Eastern patients undergoing percutaneous coro-
ry intervention study, J Saudi Heart Assoc (2016), http://dx.doi.org/
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HTN DM Hyperchol Smoking FH pCVD Obesity
 62.3% 
53.6% 
48.8% 
 43.5% 
39.4% 
28.8% 
Figure 1. Overall prevalence of the six cardiovascular risk factors. DM = diabetes mellitus; FH pCVD = family history of premature
cardiovascular disease; HTN = hypertension; hyperchol = hypercholesterolemia.
One RF Two RF Three RF Four RF Five RF Six RF
14.1% 
24.6% 
27.9% 
19.6% 
8.7% 
1.2% 
Figure 2. Proportions of patients who have one or more of the six risk factors (hypertension, diabetes mellitus, hypercholesterolemia, obesity,
cigarette smoking, and family history of premature cardiovascular disease).
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and 38.6% of smokers. The RFmost likely to coexist
with at least four RFs was obesity (25.6%), followed
by hypercholesterolemia (19.2%).
The prevalence of RFs was evaluated according
to age (Fig. 3). The presence of two or more RFs
was observed in more patients aged 41–65 years
of age compared with younger and older patients.
The presence of three or more RFs was observed
in 60.1% of patients in the middle age group, com-
pared with 52.0% of older and 48.3% of younger
patients (p = 0.017). Furthermore, the presence of
four or more RFs was observed in 32.8% of
patients in the middle age group, compared with
22.5% of older and 20.2% of younger patients
(p = 0.007).
The prevalence of RFs in 500 women was com-
pared with that in 1926 men (Fig. 4). Absence of
any RF was observed in more men than women
(4.5% vs. 1.2%, p < 0.001). Women were more likelyPlease cite this article in press as: Hammoudeh A.J. et al., Cardiovascular r
nary intervention: Results from the first Jordanian percutaneous corona
10.1016/j.jsha.2016.10.002than men to have at least three RFs (69.0% vs.
54.5%) or at least four RFs than men (35.6% vs.
28.0%, p < 0.001).Discussion
The main findings of this study are as follows:
(1) HTN, DM, and hypercholesterolemia were
the most prevalent RFs, and each was present in
nearly half of this Middle Eastern contemporary
PCI population; (2) coexistence of two or more car-
diovascular RFs was the rule, not the exception,
where 82% have two or more RFs, 55% three or
more RFs, and 30% four or more RFs; and (3) more
women than men, and patients 41–65 years of age
compared with younger and older age groups had
a higher prevalence of two or more RFs. The 12
participating centers perform about 80% of all
PCI procedures in the country. These centers cover
most of the local healthcare sectors includingisk factors in Middle Eastern patients undergoing percutaneous coro-
ry intervention study, J Saudi Heart Assoc (2016), http://dx.doi.org/
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Table 2. Number of risk factors (0–5) coexisting with hypertension, diabetes mellitus, smoking, hypercholesterolemia, and obesity.
Risk factor No. of coexisting risk factors
0 (%) 1 (%) 2 (%) 3 (%) 4 (%) 5 (%)
Smoking 12.3 22.9 26.2 22.4 13.4 2.8
Diabetes 4.9 18.2 32.0 28.3 14.4 2.2
Hypertension 4.4 20.1 32.5 27.5 13.6 1.9
Obesity 3.9 13.9 27.5 29.2 21.5 4.1
Hypercholesterolemia 1.6 13.8 33.6 31.8 16.7 2.5
One RF Two RF Three RF Four RF Five RF Six RF
<41 Y
41-65 Y
>65 Y
20.2%
 
13.5%
 
14.4%
 
28.1%
 
22.8%
 
28.9%
 
28.1%
 
27.3%
 
29.5%
 
12.3%
 
21.6%
 
15.6%
 
6.1%
 
6.6%
 
9.7%
 
1.8%
 
1.5%
 
      0.3%
 
Figure 3. Proportions of patients in three age groups (younger than 41 years, 41–65 years, and older than 65 years of age) who have one or more
of the six risk factors (hypertension, diabetes mellitus, hypercholesterolemia, obesity, cigarette smoking, and family history of premature
cardiovascular disease). RF = risk factor.
One RF Two RF Three RF Four RF Five RF Six RF
Men
Women15.4% 
8.8% 
25.6% 
 21.0% 
26.5% 
33.4% 
18.7% 
23.2% 
8.1% 
11.4% 
1.2% 1.0% 
Figure 4. Proportions of men and women who have one or more of the six risk factors (hypertension, diabetes mellitus, hypercholesterolemia,
obesity, cigarette smoking, and family history of premature cardiovascular disease). RF = risk factor.
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CVD RISK FACTORS AND PERCUTANEOUS
CORONARY INTERVENTIONpublic, university, and nonteaching private and
teaching private hospitals. Thus, the studied
group of PCI patients fairly represents the whole
PCI patient population.
Conventional cardiovascular RFs are broadly
classified into two categories: modifiable and non-
modifiable factors [3,5]. Modifiable RFs can reducePlease cite this article in press as: Hammoudeh A.J. et al., Cardiovascular r
nary intervention: Results from the first Jordanian percutaneous corona
10.1016/j.jsha.2016.10.002the CVD risk if treated and controlled, and non-
modifiable RFs are not amenable to adjustment
or control, e.g., age, sex, family history of CVD,
and ethnicity. Other than the five modifiable RFs
studied in this registry (HTN, DM, cigarette smok-
ing, hypercholesterolemia, and obesity), the list
includes sedentary lifestyle, bad nutritionalisk factors in Middle Eastern patients undergoing percutaneous coro-
ry intervention study, J Saudi Heart Assoc (2016), http://dx.doi.org/
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tion, low educational level, urbanization, poor
housing quality, and pollution [3,5,17–19]. Several
studies have demonstrated that these modifiable
RFs are responsible for a large number of prema-
ture CV deaths worldwide and in the low- and
middle-income countries [20,21].
The finding that over 90% of patients with CAD
had at least one RF in the majority of these
patients concurs with other investigators’ findings
[8,10,13,18,22,23]. Studies have shown that multi-
ple RFs are more prevalent among lower social
class households, singles, and people who are eco-
nomically inactive, and less prevalent among
homeowners and older age groups [22]. Coexis-
tence of RFs varies across populations studied,
that is, populations in different geographic
regions in the world, urban versus rural popula-
tions, different ethnic groups within the same
country, individuals who do not have overt CVD
compared with those who have symptomatic
CVD, men versus women, and old versus young
individuals [24,25]. An outpatient clinic-based
study in 14 Middle Eastern and African nations
showed that the presence of three or more RFs
was observed in more than half (53%) of the over-
all cohort [10]. This rate ranged from 33% in low-
income countries to 57% in high-income countries.
In a local study of 1534 individuals who had symp-
tomatic CAD, two RFs were present in 28% and
three in 25% of the patients, and the presence of
three or less RFs was observed in 41% of patients
[8].
The rate of coexistence of RF was shown by sev-
eral studies to suddenly drop, after a threshold of
three RFs, to a fairly low level [26]. This study has
demonstrated that the coexistence of RFs dropped
suddenly to a single digit percentage (<10%) at a
threshold of four RFs, reflecting a worse risk pro-
file among the study individuals, all of whom
had undergone PCI.
The study also showed that multiple RF coexis-
tence varies according to age and gender. The
presence of three or more RFs was observed in
six of 10 middle-aged patients, compared with
about five of 10 of younger and older age groups.
RF coexistence dropped to a single-digit percent-
age after four RFs in the three age groups. The
observation of a decreasing prevalence of RFs
among the older age group compared with those
aged 41–65 years is due to the fact that age per se
steadily increases the absolute baseline risk of
CAD independent of the conventional RFs; there-
fore, patients without RFs tend to present at a
much later age once their baseline absolute riskPlease cite this article in press as: Hammoudeh A.J. et al., Cardiovascular r
nary intervention: Results from the first Jordanian percutaneous corona
10.1016/j.jsha.2016.10.002increases sufficiently to cause a significant preva-
lence of CAD. Furthermore, the decreasing preva-
lence of RFs in the older patients reflects an
inherent survivor bias because patients with con-
ventional RFs die at a much younger age [27].
Recent evidence from the ongoing sex-specific
research has demonstrated that although men
and women share similar RFs for CAD, certain
RFs, such as cigarette smoking, DM, depression,
and other psychosocial RFs, tend to exert a worse
health impact in women [28]. It has been sug-
gested that nine potentially modifiable RFs (smok-
ing, HTN, DM, waist-to-hip ratio, dietary patterns,
physical activity, alcohol consumption, plasma
apolipoproteins, and psychosocial factors) account
for 96% of the population-attributable risk of
myocardial infarction in women [5,21]. Overall,
the prevalence of RFs is greater in women than
in men, and women are more likely to have a
higher number of cardiovascular RFs [23,27]. The
current study showed that about seven of 10
women had three or more RFs, and four of 10
had four or more RFs. Furthermore, the sudden
drop in the number of RFs to a single digit
observed in men after the coexistence of four
RFs occurred in women after five RFs.
Among enrolled patients who had HTN, the
most prevalent other RF seems to be hypercholes-
terolemia [28,29]. This study showed that among
patients with HTN, 62% also had DM and 60%
had hypercholesterolemia. Moreover, among
patients with DM, 72%, 57%, and 36% had HTN,
hypercholesterolemia, and smoking, respectively.
The presence of other RFs among diabetic patients
predicts higher mortality and necessitates aggres-
sive medical therapy [30,31]. The two most com-
mon RFs coexisting with hypercholesterolemia in
this study were HTN (77%) and DM (63%). Simi-
larly, obesity coexisted with HTN in 69% and with
DM in 57% of patients.
Contributory causes to the high prevalence of
coexistence of multiple RFs include growing pop-
ulation with demographic shifts, an altered age
profile, low education levels, lifestyle changes
due to urbanization, dietary habits, lack of adop-
tion of regular physical activity in a large propor-
tion of the population, ineffective antitobacco
campaigns, and rise of prevalence rates of DM,
metabolic syndrome, and obesity [30,32–34].
Patients with multiple RFs are at increased risk
of having coronary artery calcification, and prema-
ture mortality and morbidity [13,35]. The
population-attributable risk for these RFs was
higher in the Middle East than in other regions
of the world, highlighting the substantial potentialisk factors in Middle Eastern patients undergoing percutaneous coro-
ry intervention study, J Saudi Heart Assoc (2016), http://dx.doi.org/
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measures. Primary prevention strategies contin-
gent on early detection and adequate control of
conventional RFs are critical to combat the global
burden of CVD.
A few limitations in our study warrant discus-
sion. Inherent to similar observational registries,
this study is subject to selection bias, collection
of nonrandomized data, and missing or incom-
plete information [36]. Some of the cardiovascular
RFs may be subject to information and/or recall
bias since the data were self-reported. Participa-
tion was voluntary and the enrolment of consecu-
tive patients was encouraged, but this was not
verified, as it is the case with other registries.
ACS patients who died before or shortly after
admission and those who did not undergo angiog-
raphy were not represented in this study. The
mere presence of a particular RF in an individual
patient with CVD does not guarantee that it plays
a causal role in the pathogenesis of atherosclerosis
due to the coexistence of nontraditional RFs and
genetic causes at the individual level. Other than
high levels of total cholesterol, levels of high- or
low-density lipoproteins were not considered in
the RF analysis. Inclusion of high-density lipopro-
tein cholesterol, a highly prevalent finding in Mid-
dle Eastern men and women [8], would diminish
the number of patients who do not have any of
the conventional RFs. BMI, rather than the waist
circumference, was used to define obesity.
Although BMI is easy to calculate and commonly
used in registries, it is a crude and flawed anthro-
pometric biomarker that lacks the discriminating
power in differentiating between lean body mass
and fat mass. Despite these limitations, this study
is unique in that it evaluated the prevalence and
coexistence of six RFs in a relatively large cohort
who underwent PCI in the Middle East, a region
that is not well presented in cardiovascular inter-
ventional studies and registries.
In conclusion, the high prevalence of the six car-
diovascular RFs in this Middle Eastern PCI cohort
is a viable concern for patients and for the com-
munity at large. The coexistence of multiple RFs
provides a clear impression of the true burden of
CVD risk in the population, emphasizing the
urgent need to support the concept of multi-
faceted primary and secondary cardiovascular
preventive medical and behavioral interventions.Acknowledgments
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